TY - JOUR
T1 - Terapia hormonal en la transición femenino a masculino (ftm), androgénica, para trans masculino o para hombre transgénero
AU - Adauy, Arlette
AU - Sandoval, Jorge
AU - Ríos, Rafael
AU - Cartes, Alejandra
AU - Salinas, Hugo
N1 - Publisher Copyright:
© 2018 Sociedad Chilena de Obstetricia y Ginecologia. All Rights Reserved.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Transsexuality, or being transgender according to the current nomenclature, describes people who persistently seek to be accepted as members of the opposite sex, wish to change their primary and / or secondary sexual characteristics through both hormonal and surgical medical interventions to feminize or masculinize themselves.(Table 1) This discordance between their "biological" and "psychological" sex, generates clinically significant stress with profound rejection of the body of the anatomical sex, the gender assigned at birth and, therefore, persistent alteration in daily functioning (more than 6 months), is called gender dysphoria feel that they were born in the “wrong Body”. The goal of medical intervention is to improve gender dysphoria and, consequently, improve the well-being and quality of life of transgender people. In the Journal of the Chilean Society of Obstetrics and Child and Adolescent Gynecology, we have recently published two review articles on the introduction of Hormonotherapy in transgender people, goals of therapy, transition in adolescence, and the male-to-female transition, so this paper will focus only on Hormonal Therapy of the female to male transition (FTM), are people who transit from woman to man, or male trans, male transgender. (1,2).
AB - Transsexuality, or being transgender according to the current nomenclature, describes people who persistently seek to be accepted as members of the opposite sex, wish to change their primary and / or secondary sexual characteristics through both hormonal and surgical medical interventions to feminize or masculinize themselves.(Table 1) This discordance between their "biological" and "psychological" sex, generates clinically significant stress with profound rejection of the body of the anatomical sex, the gender assigned at birth and, therefore, persistent alteration in daily functioning (more than 6 months), is called gender dysphoria feel that they were born in the “wrong Body”. The goal of medical intervention is to improve gender dysphoria and, consequently, improve the well-being and quality of life of transgender people. In the Journal of the Chilean Society of Obstetrics and Child and Adolescent Gynecology, we have recently published two review articles on the introduction of Hormonotherapy in transgender people, goals of therapy, transition in adolescence, and the male-to-female transition, so this paper will focus only on Hormonal Therapy of the female to male transition (FTM), are people who transit from woman to man, or male trans, male transgender. (1,2).
KW - Gender dysphoria
KW - Hormone therapy in transgender
KW - Male transgender
KW - Transgender
KW - Transition from female to male
UR - http://www.scopus.com/inward/record.url?scp=85061474164&partnerID=8YFLogxK
U2 - 10.4067/s0717-75262018000300319
DO - 10.4067/s0717-75262018000300319
M3 - Artículo
AN - SCOPUS:85061474164
SN - 0048-766X
VL - 83
SP - 318
EP - 328
JO - Revista Chilena de Obstetricia y Ginecologia
JF - Revista Chilena de Obstetricia y Ginecologia
IS - 3
ER -